AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano TransMed Article
PDF (1.1 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

The era of translational nanomedicine

Centre of Regenerative Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China
Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School Cambridge, MA 02139, USA
Show Author Information

References

1

Haynes, B. F. A new vaccine to battle Covid-19. N. Engl. J. Med. 2020, 384, 470-471.
Crossref Google Scholar
2

Ball, P. The lightning-fast quest for COVID vaccines — and what it means for other diseases. Nature 2021, 589, 16-18.
Crossref Google Scholar
3
Weissig, V. Liposomes came first: The early history of liposomology. In Liposomes: Methods and Protocols. D'Souza, G. G. M., Ed.; Springer: New York, 2017; pp 1-15.https://doi.org/10.1007/978-1-4939-6591-5_1
Crossref
4

He, H. L.; Liu, L. S.; Morin, E. E.; Liu, M.; Schwendeman, A. Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures. Acc. Chem. Res. 2019, 52, 2445-2461.
Crossref Google Scholar
5

Hassan, S.; Prakash, G.; Ozturk, A. B.; Saghazadeh, S.; Sohail, M. F.; Seo, J.; Dokmeci, M. R.; Zhang, Y. S.; Khademhosseini, A。Evolution and clinical translation of drug delivery nanomaterials. Nano Today 2017, 15, 91-106.
Crossref Google Scholar
6

Dvir, T.; Timko, B. P.; Kohane, D. S.; Langer, R. Nanotechnological strategies for engineering complex tissues. Nat. Nanotechnol. 2011, 6, 13-22.
Crossref Google Scholar
7

Zheng, Y. Y.; Hong, X. Q.; Wang, J. T.; Feng, L. B.; Fan, T. J.; Guo, R.; Zhang, H。2D nanomaterials for tissue engineering and regenerative nanomedicines: Recent advances and future challenges. Adv. Healthcare Mater. 2021, 10, 2001743.
Crossref Google Scholar
8

Ravanbakhsh, H.; Bao, G. Y.; Luo, Z. Y.; Mongeau, L. G.; Zhang, Y. S. Composite inks for extrusion printing of biological and biomedical constructs. ACS Biomater. Sci. Eng. 2021, 7, 4009-4026.
Crossref Google Scholar
9

Pirzada, M.; Altintas, Z. Nanomaterials for healthcare biosensing applications. Sensors 2019, 19, 5311.
Crossref Google Scholar
10

Kevadiya, B. D.; Machhi, J.; Herskovitz, J.; Oleynikov, M. D.; Blomberg, W. R.; Bajwa, N.; Soni, D.; Das, S.; Hasan, M.; Patel, M. et al。Diagnostics for SARS-CoV-2 infections. Nat. Mater. 2021, 20, 593-605.
Crossref Google Scholar
11

Lee, D. E.; Koo, H.; Sun, I. C.; Ryu, J. H.; Kim, K.; Kwon, I. C。Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 2012, 41, 2656-2672.
Crossref Google Scholar
12

Han, X. J.; Xu, K.; Taratula, O.; Farsad, K. Applications of nanoparticles in biomedical imaging. Nanoscale 2019, 11, 799-819.
Crossref Google Scholar
Nano TransMed
Volume 1 Issue 1,
March 2022
Article number: 9130006
DOI: 10.26599/NTM.2022.9130006
Cite this article:
Ye Q, Zhang YS. The era of translational nanomedicine. Nano TransMed, 2022, 1(1): 9130006. https://doi.org/10.26599/NTM.2022.9130006

2179

Views

333

Downloads

4

Crossref

Altmetrics
Received: 22 March 2022
Accepted: 22 March 2022
Published: 22 March 2022
© The Author(s) 2022. Nano TransMed published by Tsinghua University Press.

The articles published in this open access journal are distributedunder the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use,distribution and reproduction in any medium, provided the original work is properly cited.
Return